LCI snaps up Pfizer’s manufacturing facility

MG News | September 09, 2024 at 09:24 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): Marking a significant expansion in LCI's pharmaceutical footprint, Lucky Core Industries Limited (PSX: LCI) has acquired Pfizer Pakistan Limited's manufacturing facility under the Asset Purchase Agreements entered into between the parties.

Along with this, the company has also acquired the products and product registrations consisting of Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D and Mycitracin.

In addition to this trademarks associated with the said pharmaceutical products either through an outright assignment of trademarks or a perpetual license to use the relevant trademarks from relevant Pfizer group entities have also been acquired.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	170,765.22 212.46M	0.16% 266.28
ALLSHR	103,241.06 481.66M	0.13% 137.96
KSE30	50,813.89 65.25M	0.15% 74.20
KMI30	244,391.30 71.96M	0.08% 186.13
KMIALLSHR	66,928.26 309.74M	0.08% 55.24
BKTi	47,274.31 12.11M	0.30% 141.41
OGTi	35,009.43 4.22M	0.13% 46.86

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	84,515.00	84,515.00 84,120.00	95.00 0.11%
BRENT CRUDE	104.38	106.59 103.11	-2.22 -2.08%
RICHARDS BAY COAL MONTHLY	123.00	0.00 0.00	-0.55 -0.45%
ROTTERDAM COAL MONTHLY	136.55	137.10 133.60	0.65 0.48%
USD RBD PALM OLEIN	1,167.50	1,167.50 1,167.50	0.00 0.00%
CRUDE OIL - WTI	92.44	94.75 91.51	-2.17 -2.29%
SUGAR #11 WORLD	18.54	18.75 18.43	-0.07 -0.38%